Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAOR.L Regulatory News (AOR)

  • There is currently no data for AOR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM and Share Capital Reorganisation

24 Sep 2015 12:05

RNS Number : 1073A
AorTech International PLC
24 September 2015
 

 

AorTech International plc

 

(the "Company")

 

Result of AGM and Share Capital Reorganisation

AorTech International plc (AIM: AOR), the biomaterials and medical device IP company, is pleased to announce that at the Annual General Meeting held today, all the resolutions were duly passed.

Accordingly, the proposed share consolidation of the Company's share capital ("Share Capital Reorganisation") will become effective on the record date, being 6.00 p.m. today, 24 September 2015.

Under the Share Capital Reorganisation each of the ordinary shares of 250 pence each in the capital of the Company ("the Existing Ordinary Shares") which at 6pm on 24 September 2015 are shown in the books of the Company to be in issue shall be sub-divided into one new ordinary share of 5 pence in the capital of the Company (each a "New Ordinary Share") and one new deferred share of 245 pence in the capital of the Company (each a "Deferred Share"), such shares having the rights and being subject to the restrictions set out in the Company's articles of association.

 

Application has been made for the 4,832,778 New Ordinary Shares to be admitted to trading on AIM ("Admission") and dealings are expected to commence at 8.00 a.m. on 25 September 2015 with the existing ISIN GB0033360586.

 

Following the Share Capital Reorganisation there will be 4,832,778 New Ordinary Shares in issue. The Company does not hold any shares in treasury. Therefore the total number of shares with voting rights in the Company following Admission will be 4,832,778. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company.

 

This information is provided by RNS

For further information contact:

 

AorTech International plc 

Eddie McDaid, Chief Executive Tel: +44 (0)7802 920869

 

AorTech International plc 

Bill Brown, Chairman Tel: +44 (0)7730 718296 

 

finnCap Limited

Jonny Franklin-Adams/ Giles Rolls Tel: +44 20 7220 0500 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGSEEFFLFISESU
Date   Source Headline
17th Jun 20207:00 amRNSChange of Name and Rebranding
8th Jun 20207:00 amRNSUpdate on Elective Surgery and Customer Orders
27th May 20207:00 amRNSNew Patent
20th May 20207:00 amRNSGrant Funding for Subsidiary
13th May 20207:00 amRNSTrading Update
14th Apr 202010:27 amRNSFurther Update re COVID-19
2nd Apr 20202:13 pmRNSHolding(s) in Company
1st Apr 20201:36 pmRNSDirector/PDMR Shareholding
31st Mar 202010:28 amRNSResult of General Meeting and Total Voting Rights
30th Mar 20203:37 pmRNSUpdate re Acquisition of RUA and COVID-19
25th Mar 20207:00 amRNSUpdate re Acquisition and General Meeting
11th Mar 20207:00 amRNSProposed Acquisition of RUA Medical & Name Change
21st Jan 20207:00 amRNSExtension to Agreement with RUA Medical
6th Jan 20207:00 amRNSHeart Valve Development Update
2nd Dec 20197:00 amRNSNew Share Option Scheme and Grant of Share Options
29th Nov 20197:00 amRNSHalf-year Report
27th Nov 20191:09 pmRNSNew Licence Agreement
11th Oct 20197:00 amRNSTrading Update
3rd Sep 20191:14 pmRNSHolding(s) in Company
19th Aug 20192:53 pmRNSResult of AGM
5th Aug 20191:36 pmRNSPosting of Report & Accounts and Notice of Meeting
29th Jul 201912:52 pmRNSHolding(s) in Company
17th Jul 20197:00 amRNSFinal Results
8th Jul 201911:05 amRNSSecond Price Monitoring Extn
8th Jul 201911:00 amRNSPrice Monitoring Extension
19th Jun 20197:01 amRNSChange of Adviser
19th Jun 20197:00 amRNSDirectors' Disclosures
17th Jun 201910:47 amRNSDirectors' Disclosures
14th May 20197:00 amRNSTrading Update
24th Jan 201912:36 pmRNSCompany Update
22nd Nov 20187:00 amRNSInterim Results
15th Oct 20185:34 pmRNSHolding(s) in Company
5th Sep 20187:00 amRNSHolding(s) in Company
30th Aug 201811:18 amRNSHolding(s) in Company
23rd Aug 20182:03 pmRNSResult of AGM
23rd Aug 20187:00 amRNSAGM Statement
26th Jul 20183:33 pmRNSHolding(s) in Company
25th Jul 20184:40 pmRNSSecond Price Monitoring Extn
25th Jul 20184:35 pmRNSPrice Monitoring Extension
20th Jul 20187:00 amRNSFinal Results
4th Jul 20187:00 amRNSNew Patent Issued
28th Jun 20187:00 amRNSDevelopment and Supply Agreement with RUA Medical
26th Jun 201812:49 pmRNSNew Patent Issued
19th Jun 20189:30 amRNSDevelopment Agreement Signed
15th Jun 20183:54 pmRNSHolding(s) in Company
13th Jun 201811:47 amRNSHolding(s) in Company
8th Jun 201812:02 pmRNSResult of GM and TVR
8th Jun 20187:00 amRNSResult of Open Offer
22nd May 201812:00 pmRNSPosting of Circular
21st May 20187:00 amRNSConditional Placing and Proposed Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.